A Study to Assess Deucravacitinib Safety in Pregnancy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study to Assess Deucravacitinib Safety in Pregnancy — Stella

Home/Psoriasis (PsO)/

View on ClinicalTrials.gov

Recruiting

Back to Psoriasis (PsO) trials

Trial locations(1 site)

United States

University of California San Diego, La Jolla, California

Key details

Sponsor

Bristol-Myers Squibb

Enrollment target

~900 participants

Started

March 2025

Primary completion

April 2028

Sex

Female only

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.